The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hahahaha! The gravy train will carry on with the phase 1 cancer trials in the middle of the year as well as the JVs with LG Chem (worth £400m about the same as the ODX contract xD), Daewoong pharma, Moderna, ADC. Not forgetting the already licenced affimers to Deepverge, Biokit, Astrea.
Not sure how far the ODX gravy train will travel once the government pulls the rug on testing. I know what train I'd rather be on.
It certainly won't be used to open up footy stadiums, Wimbledon, cricket, rugby stadia anytime soon
Night night hun.....
What happened to to bees knees that was the antibody test????? The same test a few months ago this board thought would take the UK out of lockdown. Any orders for them???
Hahaha my eyes are firmly on the prize....but have a word with Colin. Tell him to sort it out. Cr*p comms and when he does give you something the share price tanks?.
This individual claims avacta shareholders don't know the difference between ODX and avacta and how avacta holders don't know both companies are not direct competitors.
This guy is dumber than I thought. Someone explained it simply. Avacta are iPhone and odx are the Chinese manufacturer. Simple enough right? We both need each other but we both know who makes the billions.
Talking about knowing things. Wasn't this the same board that a few months ago thought antibody tests were the bees knees? And that antibody tests were the way out of lockdown?
How many did the government buy? Or anyone else for that matter or any other future orders?
Hahaha you mean like you made and stockpiled all those antibody tests. How many of those did odx sell? How many did the government buy?
Just a deflection because you know you have no answer to this. ****head. Haha. How's the millions of antibody tests you were going to sell which were to be used with the AZN vaccine selling?
Prionace do toy SERIOUSLY believe the avacta board don't know odx and avacta are not direct competitors. FFS. You are more ******ed than I thought! This same board that doesn't even know the difference between an antigen and antibody test. This same board that a few months ago thought an antibody test was the bees knees.
FFS you are the biggest numpty I've ever seen prionace with those comments.
Just a bit annoying I think not really funny....I mean is the sp dropping after good news funny too?
Didn't mologic announce TT last October with ODX? So if they haven't commenced TT yet, surely it cannot be for mologic as they already commenced that TT right?
How many have they started manufacturing? You can only make a product once avacta or mologic get theirs out. The irony! How many tests are odx churning out at the moment, how many millions?
What happened to the mologic TT that commenced last October? Is it still ongoing?
Prionace yes avacta have no test yet
What avacta do have is
Oncology x 11
Ava6000,AVA7500,
AVA028,AVA7000,AVA004
AVA027,AVA3996 plus 4 undisclosed targets
Covid x 5
Affidx, Bams,Elisa,
Mologic combination test.
Plus in house pipe line non-COVID diagnostic tests, which include assays for D-dimer, cortisol, vitamins D and B12 and CRP.
LG Chem x 8
Every RNS states a multi-target deal with LG Chem worth up to $400m.
In the business update $98 million for the 2 below and up to $55m for each new product
So LG Chem has potentially 8 new products.
multi-target collaboration with LG Chem incorporating Avacta's Affimer XT™ serum half-life extension and LG Chem has Affimer PD-L1 inhibitortotalling $98million
The expanded partnership also provides LG Chem with rights to develop and commercialise other Affimer and non-Affimer biotherapeutics combined with Affimer XT half-life extension for a range of indications and Avacta could earn an additional $55m in milestone payments for each of these new products.
Daewoong x 2
Gene & stem cell with other targets
Point x 1
radiopharmaceutical prodrug
ADC x 3
three undisclosed cancer targets and provide these to ADC Therapeutics
Moderna x 1
exclusive license agreement with respect to certain Affimer molecules
Astrea x 1
Deepverge x 1
Biokit x 1
But they don't have a test out yet :D
Precisely why I am here as well picarthartes. Correcting prionaces false statements where he even backtracked on his own JV comment.
Prionace the fact you had to throw an insult as you had nothing else to back up what you say settles it right there. Goodbye
What has ncyt got to do here????? You don't have an answer the the NUMEROUS JVs and licensing deals so bring in a 3rd company who only really have a pcr test to their name. Facepalm. Clutching at straws.
'Not really Bubba. It is a JV in all essence. They have provided ODX with equipment to carry out the job, have named them as one of the 3 providers and have just awarded them a tender.
Not hard to understand. But you've only been here since last year so you may not know......'
'Just the Govt eh Bubba123!
Providing equipment....awarding us tenders. Is that not a JV? You are such a clueless muppet :)'
1 minute it is a joint venture and then the next it isn't prionace?? Double standards or what!
I suppose when you compare it to a PROPER JV you would question it.....
Aha! Finally we are getting somewhere prionace!
'Decent place to buy NYCT after it's heavy drop. Watch out for the AVCT sell off if you're in there.'
The above are just a FEW of numerous reasons why you won't see an Avacta sell off. In fact the past few weeks have seen the opposite. As you have so plainly stated, ODX are just a manufacturering company.....
Talk about scrapping the bottom of the barrel in terms of a JV. I suppose a company who can only manufacture for others can't really aspire for greater JVs (if you can call that a JV). Like I don't know with LG Chem or Moderna (yes that same one with the covid jab) or daewoong pharm(biggest in s korea) and let's not get started on licensing agreements.....
You call the government contract a JV?? And you call Me a muppet?? Serious issues here.....